Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-1.32 %
$ 22.3 M
Market Cap
-0.27
P/E
LGVN - REVENUE
Revenue LGVN - Longeveron Inc.
709 K
LAST VALUE
-26.32%
2 YEAR CAGR
-19.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR